...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great surge in PPS for fellow RVX investers

tada, reading it again, I think you're right.  Well, that's a relief. 

Share
New Message
Please login to post a reply